Functional effects of long term ICS treatment in controlled asthma

A. Petroianni, V. Conti, E. Lemontzi, I. Mininni, F. Oriolo, V. D‘Alù, L. Locorriere, C. Terzano (Rome, Italy)

Source: Annual Congress 2011 - Asthma: control and treatment
Session: Asthma: control and treatment
Session type: Thematic Poster Session
Number: 895
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Petroianni, V. Conti, E. Lemontzi, I. Mininni, F. Oriolo, V. D‘Alù, L. Locorriere, C. Terzano (Rome, Italy). Functional effects of long term ICS treatment in controlled asthma. Eur Respir J 2011; 38: Suppl. 55, 895

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of inhaled corticosteroids on the hypothalamic-pituitary-adrenal-axis in short term and long term treatment
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids
Source: Eur Respir J 2004; 24: Suppl. 48, 614s
Year: 2004

Effect of inhaled steroids on long term prognosis of lung function in adults with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 664s
Year: 2004

Long term effect of Omalizumab on severe asthma
Source: International Congress 2017 – Asthma management
Year: 2017

Clinical benefits and safety of long term treatment with Montelukast in children with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 525s
Year: 2002

Omalizumab improves asthma in long term therapy
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012

Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Clinical evolution of potroom asthma - effects of introducing montelukast to standard treatment with corticosteroid and beta-agonists
Source: Eur Respir J 2001; 18: Suppl. 33, 278s
Year: 2001

Comparing the 'real-world' effectiveness of daily ICS versus daily leukotriene antagonist with ICS as needed in mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 388s
Year: 2002

Assessment of long-term effects of combined extra-fine beclomethasone and formoterol treatment in asthma patients using functional imaging
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Pharmacological characterization of CHF6162, a novel long acting inhaled corticosteroid for the treatment of asthma
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019

The effect of long term treatment with erdosteine on COPD: the Equalife study
Source: Eur Respir J 2003; 22: Suppl. 45, 428s
Year: 2003

Impact of omalizumab treatment persistence on asthma control
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012

Analysis of bronchodilator response in patients with controlled asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 223s
Year: 2004

The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Individual and differential treatment responses to once-daily long acting bronchodilators, glycopirronium and indacaterol, and combination of both drugs in the patients with moderate or severe COPD
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014

A long term randomized clinical study of 300 asthmatics. An internet based asthma monitoring tool improves quality of life significantly
Source: Eur Respir J 2004; 24: Suppl. 48, 261s
Year: 2004

Effects of adding salmeterol to inhaled corticosteroids on lung function and quality of life in patients with mild persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006